Medical News

RSS

FDA and EMA accept regulatory submissions of vandetanib for advanced medullary thyroid cancer

AstraZeneca today announced that the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib in the treatment of patients with advanced medullary thyroid cancer (MTC). The FDA also granted priority review status for the new drug application and set a Prescription Drug User Fee Act (PDUFA) action date of 7 January 2011.

23 Sep 2010

Doctors misuse antibiotics to treat patients with respiratory tract infections: Study

Doctors frequently misuse antibiotics when treating patients hospitalized with respiratory tract infections (RTIs), according to a study to be published in the November issue of Infection Control and Hospital Epidemiology.

23 Sep 2010

NeoStem to present VSEL Technology for Battlefield Wounds treatment at USU-HJF Symposium

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, today announced that the Company will be presenting its Autologous Adult Stem Cell VSEL Technology for the Treatment of Battlefield Wounds at The USU-HJF Military Medicine Symposium in Washington DC, September 23rd, 2010.

23 Sep 2010

New analytical technique to improve personalized medicine

In the future, even before the start of the treatment, physicians will be able to establish how patient's blood binds a given medicine and what doze should be applied in order to obtain the concentration in the body that would be optimal for the treatment. A new simple method of analysis of chemical reactions proceeding in solutions has been developed in the Institute of Physical Chemistry of the Polish Academy of Sciences.

23 Sep 2010

Signal Genetics, Array BioPharma partner to advance personalized medicine in multiple myeloma

Signal Genetics, a privately held predictive genetic testing company focused on oncology, today announced the company will work with Array BioPharma to help push forward both companies' goals of markers for patient selection, helping bring personalized medicine and companion diagnostics to patients with multiple myeloma, a cancer of the bone marrow and antibody producing cells.

23 Sep 2010

Merck expands patient assistance programs to provide medicines to needy people

Today, Merck announced that it has significantly expanded the number of Merck medicines available through its Merck Helps patient assistance programs, which include the Merck Patient Assistance Program, the Merck Vaccine Patient Assistance Program, the ACT Program for Oncology and Hepatitis C medicines, and the SUPPORT Program for HIV/AIDS medicines.

23 Sep 2010

New health law's protections for adult children starts tomorrow

Reporting for Kaiser Health News, in collaboration with USA Today, Lisa Zamosky writes: "Parents, mark your calendars. Starting tomorrow, adult children will no longer be left to fend for themselves in their search for health insurance.

23 Sep 2010

HealthCare Insight awarded URAC accreditation in HIPAA Privacy for Business Associate and HUM modules

HealthCare Insight (HCI) announced today that it has been awarded full accreditation in HIPAA Privacy for Business Associate and Health Utilization Management (HUM) modules from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes quality standards for the health care industry.

23 Sep 2010

RXi, EyeGate collaborate to develop RNAi therapeutics for retinal disorders

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutics, and EyeGate Pharma, the leader in non-invasive ocular drug delivery announced today that they will collaborate on the ocular delivery of RNAi therapeutics. Each party will contribute technology, expertise, and resources to the collaboration.

23 Sep 2010

FDA approves Roche's COBAS AmpliPrep / COBAS TaqMan HBV Test v2.0

Roche Molecular Diagnostics announced today that the U.S. Food & Drug Administration (FDA) has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in the United States. The new Roche test provides a fully automated solution for the quantitative detection of hepatitis B virus (HBV) DNA in human plasma or serum for patients on HBV antiviral therapy.

23 Sep 2010

Mitsui Ventures invests US$5 million to support S*BIO's clinical program

S*BIO Pte Ltd today announced a US$5 million investment by Mitsui Ventures that will support the continued development of S*BIO's clinical programs.

23 Sep 2010

Obama takes health reform on the road, touts key consumer provisions

President Obama Wednesday took to the suburbs of Washington, D.C. to tout provisions of the new health law that protect consumers. These changes go into effect Thursday.

23 Sep 2010

DuPont and Royal DSM enter joint venture for advanced surgical biomedical materials

DuPont and Royal DSM N.V. announce an agreement to form a joint venture to develop, manufacture and commercialize advanced surgical biomedical materials, pending European Union regulatory approval. The joint venture will be named Actamax Surgical Materials LLC. Under the joint venture agreement, DuPont and DSM will each share a 50 percent interest.

23 Sep 2010

Miltenyi Biotec releases ACSA-1 MicroBead Kit to isolate GLAST-expressing astrocytes

Miltenyi Biotec announces the worldwide first and exclusive release of the Anti-GLAST (ACSA-1) MicroBead Kit. Isolation of viable GLAST-expressing astrocytes is now possible within one hour using the first commercially available antibody against an extracellular surface epitope of GLAST.

23 Sep 2010

High selenium intake associated with lower rates of bladder cancer in women

Scientists in Spain have found that adding a can of tuna or other fish to our shopping lists could help protect us against bladder cancer.

23 Sep 2010

Medical loss ratio debate drags on, drags down stock prices

The failure to clearly define the key health law requirement that many insurers must spend at least 80 percent of premium dollars on health services has left investors tepid about health plan stocks and has complicated corporate decisions in the sector, Bloomberg reports. The National Association of Insurance Commissioners, a group of state regulators, were supposed to offer a definition to federal policy makers by June, but their deadline was pushed back to October.

23 Sep 2010

Dr. Reddy's Laboratories files Annual Report on Form 20-F

Dr. Reddy's Laboratories Limited today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2010 was filed with the United States Securities and Exchange Commission.

23 Sep 2010

Covidien launches Puritan Bennett 560 ventilator in Europe

Covidien, a leading global healthcare products company and recognized innovator in mechanical ventilation and respiratory care devices, today announced that the Puritan Bennett™ 560 ventilator is now available in Europe. The Puritan Bennett 560 ventilator is compact and portable, weighing just 4.5 kg. This lightweight device provides mobile respiratory support, enabling ventilated adult and pediatric patients to pursue regular activities with peace of mind.

23 Sep 2010

FDA approves fingolimod drug for multiple sclerosis

The first oral medication for multiple sclerosis was approved today by the Food & Drug Administration. Physicians praised the decision to approve the drug, called fingolimod, saying it would give multiple sclerosis patients new options for treatment.

23 Sep 2010

Masonic Cancer Center receives five-year program project research grants from NCI

Two of the University of Minnesota Masonic Cancer Center's leading physician-scientists on research and treatment of cancers of the blood and bone marrow Philip McGlave, M.D., and Jeffrey Miller, M.D., have received renewed five-year program project research grants totaling almost $26 million from the National Cancer Institute (NCI).

23 Sep 2010

Medical News

FDA and EMA accept regulatory submissions of vandetanib for advanced medullary thyroid cancer

Doctors misuse antibiotics to treat patients with respiratory tract infections: Study

NeoStem to present VSEL Technology for Battlefield Wounds treatment at USU-HJF Symposium

New analytical technique to improve personalized medicine

Signal Genetics, Array BioPharma partner to advance personalized medicine in multiple myeloma

Merck expands patient assistance programs to provide medicines to needy people

New health law's protections for adult children starts tomorrow

HealthCare Insight awarded URAC accreditation in HIPAA Privacy for Business Associate and HUM modules

RXi, EyeGate collaborate to develop RNAi therapeutics for retinal disorders

FDA approves Roche's COBAS AmpliPrep / COBAS TaqMan HBV Test v2.0

Mitsui Ventures invests US$5 million to support S*BIO's clinical program

Obama takes health reform on the road, touts key consumer provisions

DuPont and Royal DSM enter joint venture for advanced surgical biomedical materials

Miltenyi Biotec releases ACSA-1 MicroBead Kit to isolate GLAST-expressing astrocytes

High selenium intake associated with lower rates of bladder cancer in women

Medical loss ratio debate drags on, drags down stock prices

Dr. Reddy's Laboratories files Annual Report on Form 20-F

Covidien launches Puritan Bennett 560 ventilator in Europe

FDA approves fingolimod drug for multiple sclerosis

Masonic Cancer Center receives five-year program project research grants from NCI

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News